|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| Cash Flows from Operating Activities: | ||||
| Net earnings (loss) | ||||
| Adjustments to reconcile net earnings (loss) to net cash provided by operating activities: | ||||
| Depreciation and amortization | ||||
| (Gain) loss on sales of investments and other assets and asset impairments, net | ||||
| Loss on the sale of businesses | ||||
| Interest credited/index credits to contractholder account balances | ||||
| Change in market risk benefits, net | ||||
| Deferred policy acquisition costs and deferred sales inducements | ||||
| Charges assessed to contractholders for mortality and administration | ||||
| Distributions from unconsolidated affiliates, return on investment | ||||
| Stock-based compensation cost | ||||
| Change in NAV of limited partnerships, net | ||||
| Change in valuation of derivatives, equity and preferred securities and other assets, net | ||||
| Changes in assets and liabilities, net of effects from acquisitions: | ||||
| Change in reinsurance recoverable | ||||
| Change in derivative collateral liabilities | ||||
| Change in future policy benefits | ||||
| Change in funds withheld from reinsurers | ||||
| Net change in income taxes | ||||
| Net change in other assets and other liabilities | ||||
| Net cash provided by operating activities | ||||
| Cash Flows from Investing Activities: | ||||
| Proceeds from sales, calls and maturities of investments | ||||
| Additions to property and equipment and capitalized software | ||||
| Purchases of investment securities | ||||
| Net proceeds from sales, maturities and purchases of short-term investment securities | ||||
| Other acquisitions/disposals, net of cash acquired | ||||
| Additional investments in unconsolidated affiliates | ||||
| Net increase in policy loans | ||||
| Distributions from unconsolidated affiliates, return of investment | ||||
| Net change in notes receivable | ||||
| Net cash used in investing activities | ||||
| Cash Flows from Financing Activities: | ||||
| Borrowings | ||||
| Debt issuance costs | ||||
| Payment of contingent consideration for acquisitions | ||||
| Net revolving credit facility (repayments) borrowings | ||||
| Repayments of outstanding debt | ||||
| Dividends paid | ||||
| Dividends and distributions paid to non-controlling interest shareholders | ||||
| Purchases of treasury stock | ||||
| Issuance of preferred stock | ||||
| Issuance of common stock | ||||
| Contractholder account deposits | ||||
| Contractholder account withdrawals | ||||
| Net cash provided by (used in) financing activities | ||||
| Net (decrease) increase in cash and cash equivalents | ||||
| Cash and cash equivalents at beginning of period | ||||
| Cash and cash equivalents at end of period | ||||
Loading...